Skip to main
ICLR

ICON (ICLR) Stock Forecast & Price Target

ICON (ICLR) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 29%
Buy 29%
Hold 36%
Sell 7%
Strong Sell 0%

Bulls say

Icon is well-positioned to benefit from the growing demand for CRO services and management's focus on their core business and AI strategy. The company has set ambitious environmental targets and is diversely staffed, but there are concerns about potential accounting issues. In a downside scenario, the stock could reach $77, while in an upside scenario, it could reach $164, with a base case price target of $123.

Bears say

Icon is facing negative operating leverage due to past commercial softness and is investing in technology and efficiency initiatives. Positive bookings performance and partnerships in the biotech industry are driving factors in their outlook, along with an investment in Banyan BioInnovations. However, concerns about accounting practices and the potential for revenue restatements should be taken into consideration. ICON is well-positioned in the growing clinical trial industry, but the negative outlook suggests caution in terms of potential risks and uncertainties.

ICON (ICLR) has been analyzed by 14 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 29% recommend Buy, 36% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ICON and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ICON (ICLR) Forecast

Analysts have given ICON (ICLR) a Buy based on their latest research and market trends.

According to 14 analysts, ICON (ICLR) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $175.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $175.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ICON (ICLR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.